"RAP BOD have no commercial reference point $$$$$$$"
They seem to have run out of ideas. Maybe Covid - the inability to travel and for hospitals to have the time to evaluate the technology the last 2.5 years has effected the business more than we think and this has zapped the company's funds and the directors confidence.The NHS trial (which starts sometime in the third quarter which is as early as 2 weeks away) if successful will help blow the lid off the share price. I'm willing to wait.
RAP Price at posting:
17.0¢ Sentiment: Hold Disclosure: Held
